Yeztugo Interactions
There are 472 drugs known to interact with Yeztugo (lenacapavir), along with 2 disease interactions. Of the total drug interactions, 71 are major, 385 are moderate, and 16 are minor.
- View all 472 medications that may interact with Yeztugo
- View Yeztugo disease interactions (2)
Most frequently checked interactions
View interaction reports for Yeztugo (lenacapavir) and the medicines listed below.
- acetaminophen / hydrocodone
- acetaminophen / oxycodone
- acetylcysteine
- Actimmune (interferon gamma-1b)
- Activated Charcoal (charcoal)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adderall (amphetamine / dextroamphetamine)
- Addyi (flibanserin)
- Advil (ibuprofen)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Ajovy (fremanezumab)
- albuterol
- Alhemo (concizumab)
- Altuviiio (antihemophilic factor)
- Apretude (cabotegravir)
- betamethasone topical
- clindamycin topical
- Descovy (emtricitabine / tenofovir alafenamide)
- Emgality (galcanezumab)
- Farxiga (dapagliflozin)
- Mounjaro (tirzepatide)
- Nurtec ODT (rimegepant)
- Qulipta (atogepant)
- tadalafil
- Valium (diazepam)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Wegovy (semaglutide)
Yeztugo disease interactions
There are 2 disease interactions with Yeztugo (lenacapavir) which include:
Report options
QR code containing a link to this page
More about Yeztugo (lenacapavir)
- Yeztugo consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antivirals
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
